Lymphovascular invasion as a predictor of disease progression in prostate cancer

American Journal of Surgical Pathology

Volumn 24, Issue 6, 2000, Pages 859-863

  Herman, Christopher M ^a   Wilcox, George E ^a   Kattan, Michael W ^b   Scardino, Peter T ^b   Wheeler, Thomas M ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Disease progression; Lymphovascular invasion; Prostate cancer; Vascular invasion

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; DISEASE COURSE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; PROSTATECTOMY;

FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LYMPH NODE EXCISION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; SEMINAL VESICLES; TIME FACTORS;

EID: 0034086143     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200006000-00012     Document Type: Article

References (15)

1. Bahnson RR, Dresner SM, Gooding W, Becich MJ. Incidence and prognostic significance of lymphatic and vascular invasion in radical prostatectomy specimens. Prostate 1989;15:149-55.
2. Bettelheim R, Neville AM. Lymphatic and vascular channel involvement within infiltrative breast carcinoma as a guide to prognosis at the time of primary surgical treatment. Br J Cancer 1984; 50:771-7.
3. Clemente C, Boracchi P, Andreola S, DelVecchio M, Veronesi P, Rilke F. Peritumoral lymphatic invasion in patients with node-negative mammary duct carcinoma. Cancer 1992;69:1396-403.
4. Epstein JI, Partin AW, Savvagot J, et al. Prediction of progression following radical prostatectomy: a multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol 1996;20:286-92.
5. Franks LM. Latent carcinoma of the prostate. J Pathol Bacteriol 1954;68:603-14.
6. Gasparini G, Weidner N, Bevilacqua P, et al. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 1994;12:454-66.
7. Gilchrist KW, Gould VE, Hirschl S, et al. Interobserver variation in the identification of breast carcinoma in intramammary lymphatics. Hum Pathol 1982;13:170-2.
8. Henson DE, Hutter RV, Farrow G. Practice protocol for the examination of specimens removed from patients with carcinoma of the prostate gland: a publication of the Cancer Committee, College of American Pathologists. Arch Pathol Lab Med 1994;118:779-83.
9. Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 1999;17:1499-507.
10. Lee AKC, DeLellis RA, Silverman ML, Wolfe AS. Lymphatic and blood vessel invasion in breast carcinoma: a useful prognostic indicator? J Clin Oncol 1990;8:1457-65.
11. McNeal JE, Yemoto CEM. Significance of demonstrable vascular space invasion for the progression of prostate adenocarcinoma. Am J Surg Pathol 1996;20:1351-60.
12. Nime FA, Rosen PP, Thaler HT, Ashikari R, Urban JA. Prognostic significance of tumor emboli in intramammary lymphatics. Am J Surg Pathol 1977;1:25-30.
13. Salomao DR, Graham SD, Bostwick DG. Microvascular invasion in prostate cancer correlates with pathologic stage. Arch Pathol Lab Med 1995;119:1050-4.
14. Scardino PT. Early detection of prostate cancer. Urol Clin North Am 1989;16:635-55.
15. Wheeler TM. Anatomic considerations in carcinoma of the prostate. Urol Clin North Am 1989;16:623-34.